{'fraction_non_alphanumeric': 0.05649717514124294, 'fraction_numerical': 0.0480225988700565, 'mean_word_length': 4.811475409836065, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The treatment of women with hirsutism

A proportion of women who present with hirsutism may have partial 2 1 -hydroxylase deficiency: so-called non-classical, occult, attenuated or late-onset congenital adrenal hyperplasia (Jayle et al., 1958; Prunty et al., 1958; New et al., 1983). Other enzymes may also be involved (Eldar-Geva et al., 1990). If elevation of baseline follicular phase 17-OH progesterone is accepted as the criterion for diagnosis, nonclassical congenital adrenal hyperplasia accounts for between 0 and 6% of women referred to hospital with hirsutism (Chetkowski et al., 1984; Kuttenn et al., 1985; Azziz & Zacur, 1989). Others have described a higher prevalence, using different criteria.